SEC Company Response from DiaMedica Therapeutics Inc. (DMAC) (CIK 0001401040) (DMAC) — Dec 4, 2018
DiaMedica Therapeutics Inc. (DMAC) (CIK 0001401040)
Date: Dec. 4, 2018 · CIK: 0001401040 · Accession: 0001437749-18-021548
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-228313
Letter
dmtp20181204_corresp.htm
December 4, 2018
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attn: Franklin Wyman, Angela Connell, Irene Paik and Mary Beth Breslin
Re: DiaMedica Therapeutics Inc.
Registration Statement on Form S-1, as amended
File No. 333-228313
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, DiaMedica Therapeutics Inc. hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 3:30 p.m., Eastern Time, on December 6, 2018, or as soon thereafter as is practicable.
Thank you for your assistance in this matter. Should you have any questions, please call Amy Culbert of Fox Rothschild LLP at (612) 607-7287.
Very truly yours,
/s/ Rick Pauls
Show Raw Text
CORRESP 1 filename1.htm dmtp20181204_corresp.htm December 4, 2018 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attn: Franklin Wyman, Angela Connell, Irene Paik and Mary Beth Breslin Re: DiaMedica Therapeutics Inc. Registration Statement on Form S-1, as amended File No. 333-228313 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, DiaMedica Therapeutics Inc. hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 3:30 p.m., Eastern Time, on December 6, 2018, or as soon thereafter as is practicable. Thank you for your assistance in this matter. Should you have any questions, please call Amy Culbert of Fox Rothschild LLP at (612) 607-7287. Very truly yours, /s/ Rick Pauls Rick Pauls President and Chief Executive Officer